These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 3929317

  • 1. Dopamine agonist action in mesolimbic, cortical and extrapyramidal areas to modify spontaneous climbing behaviour of the mouse.
    Costall B, Eniojukan JF, Naylor RJ.
    Psychopharmacology (Berl); 1985; 86(4):452-7. PubMed ID: 3929317
    [Abstract] [Full Text] [Related]

  • 2. The mesolimbic nucleus accumbens is critically involved with the mediation of the motor inhibitory and facilitatory effects of dopamine agonists on mouse spontaneous climbing behaviour.
    Costall B, Eniojukan JF, Naylor RJ.
    Eur J Pharmacol; 1983 Dec 23; 96(3-4):201-10. PubMed ID: 6426976
    [Abstract] [Full Text] [Related]

  • 3. A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems.
    Costall B, Naylor RJ.
    Eur J Pharmacol; 1976 Nov 23; 40(1):9-19. PubMed ID: 791660
    [Abstract] [Full Text] [Related]

  • 4. The mesolimbic system, denervation and the climbing response in the mouse.
    Costall B, Fortune DH, Naylor RJ, Nohria V.
    Eur J Pharmacol; 1980 Aug 29; 66(2-3):207-15. PubMed ID: 6108225
    [Abstract] [Full Text] [Related]

  • 5. Differences in the nature of the stereotyped behaviour induced by aporphine derivatives in the rat and in their actions in extrapyramidal and mesolimbic brain areas.
    Costall B, Naylor RJ, Neumeyer JL.
    Eur J Pharmacol; 1975 Mar 29; 31(1):1-16. PubMed ID: 1168579
    [Abstract] [Full Text] [Related]

  • 6. Spontaneous climbing behaviour of mice, its measurement and dopaminergic involvement.
    Costall B, Eniojukan JF, Naylor RJ.
    Eur J Pharmacol; 1982 Nov 19; 85(2):125-32. PubMed ID: 7151866
    [Abstract] [Full Text] [Related]

  • 7. Selective antidopaminergic effects of S(+)N-n-propylnoraporphines in limbic versus extrapyramidal sites in rat brain: comparisons with typical and atypical antipsychotic agents.
    Campbell A, Yeghiayan S, Baldessarini RJ, Neumeyer JL.
    Psychopharmacology (Berl); 1991 Nov 19; 103(3):323-9. PubMed ID: 1676180
    [Abstract] [Full Text] [Related]

  • 8. Neuropharmacological studies on D145 (1,3-dimethyl-5-aminoadamantan).
    Costall B, Naylor RJ.
    Psychopharmacologia; 1975 Jul 23; 43(1):53-61. PubMed ID: 1099605
    [Abstract] [Full Text] [Related]

  • 9. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G, Depoortere R, Morel E, Sanger DJ, Scatton B.
    J Pharmacol Exp Ther; 1997 Jan 23; 280(1):73-82. PubMed ID: 8996184
    [Abstract] [Full Text] [Related]

  • 10. Inhibition and facilitation of motor responding of the mouse by actions of dopamine agonists in the forebrain.
    Bradbury AJ, Costall B, Naylor RJ.
    Neuropharmacology; 1984 Sep 23; 23(9):1025-31. PubMed ID: 6514141
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Characterisation of the mechanisms by which purported dopamine agonists reduce spontaneous locomotor activity of mice.
    Costall B, Lim SK, Naylor RJ.
    Eur J Pharmacol; 1981 Jul 17; 73(2-3):175-88. PubMed ID: 6118281
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Presynaptic dopamine receptors in the pithed rat: characterization with apomorphine and comparison with central dopamine autoreceptors.
    Hietala J, MacDonald E, Scheinin M.
    Acta Pharmacol Toxicol (Copenh); 1986 Oct 17; 59(4):291-7. PubMed ID: 3799208
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differential effect of neuroleptic drugs on dopamine turnover in the extrapyramidal and limbic system.
    Bartholini G.
    J Pharm Pharmacol; 1976 May 17; 28(5):429-33. PubMed ID: 6752
    [Abstract] [Full Text] [Related]

  • 18. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
    Castall B, Marsden CD, Naylor RJ, Pycock CJ.
    Brain Res; 1977 Mar 04; 123(1):89-111. PubMed ID: 300267
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
    Gygi SP, Gibb JW, Hanson GR.
    J Pharmacol Exp Ther; 1994 Jul 04; 270(1):192-7. PubMed ID: 7913495
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.